Brazil may be struggling in its battle against the coronavirus, but it is on the cutting edge of vaccine development with large-scale trials and the production of millions of doses on the horizon. Unlike Europe and China, COVID-19 continues to…
Read More
Proof-of-concept developed for detecting malaria parasites in India
A new approach could illuminate a critical stage in the life cycle of one of the most common malaria parasites. The approach was developed by scientists at Kyoto University’s Institute for Integrated Cell-Material Sciences (iCeMS) in Japan and published in…
Read More
Fat check: Researchers find explanation for stress’ damage in brown fat
In their search for what triggers the damaging side-effects caused by acute psychological stress, Yale researchers found an answer by doing a fat check. In the face of psychological stress, an immune system response that can significantly worsen inflammatory responses…
Read More
Discovery of new step in how brain cells work could lead to new therapies for epilepsy
Researchers have identified a critical new step in how brain cells function in people with one of the most common forms of epilepsy. This could lead to new treatment approaches for people with drug-resistant epilepsy. The study was led by…
Read More
New heart valve could transform open heart surgery for millions of patients globally
A new polymeric heart valve with a life span potentially longer than current artificial valves that would also prevent the need for the millions of patients with diseased heart valves to require life-long blood thinning tablets has been developed by…
Read More
Gilead’s $2,340 price for coronavirus drug draws criticism
The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries….
Read More
Hydroxychloroquine shortages: when the enthusiasm for a potential cure affects patients
Amid initial public and scientific optimism for hydroxychloroquine (HCQ) as a potential treatment for COVID-19, health care professionals raised concerns about shortages of this inexpensive drug, which is widely used in the treatment of several rheumatic diseases such as arthritis….
Read More
$15 billion revenue loss projected for US primary care due to COVID-19 shutdowns
Primary care practices are projected to lose more than $65,000 in revenue per full-time physician in 2020, following drastic declines in office visits and fees for services from March to May during the COVID-19 pandemic, according to a study led…
Read More
Drug used in breast and ovarian cancer could lead to safer, more effective treatment for neuroblastoma
A type of drug known as a PARP inhibitor, already used to treat breast and ovarian cancer, may be useful in treating children with high-risk neuroblastoma—a common childhood tumor with a low survival rate. Neuroblastoma is a cancer in children…
Read More
Allergic reactions due to incorrect food labeling spark calls for tighter regulations
Incorrect labeling of food products is causing too many allergic reactions and needs to be more tightly regulated, a University of Melbourne researcher says. Dr. Giovanni Zurzolo, a research fellow in the Allergy and Lung Health Unit at the Melbourne…
Read More